Following SpiD3 treatment, 4E-BP1 displaced eIF4G1 from eIF4E in the cap-bound fraction, comparable to that observed in serum-starved CLL cells (Supplementary Fig. S5). Here, EIF4EBP1 is linked to B-cell chronic lymphocytic leukemia.